~~<i id='93A6B8A2C5'><strike id='93A6B8A2C5'><tt id='93A6B8A2C5'><pre id='93A6B8A2C5'></pre></tt></strike></i>~~

Home» knowledge» hotspot

hotspot

author：explore 2025-09-06 07:39:55 Page View：21

Introducing STAT’s Biotech Q2 Scorecard, our emoji-enabled means of tracking 12 make-or-break events expected over the next three months.

When each clinical trial or FDA decision crosses the wires, we’ll add in the appropriate rocket ship, grimace face, bulging bicep or broken heart — whatever captures the mood.

Read on for brief explanations of what we’re watching for from each company.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Biden has enormous polling lead in Democratic primary, despite challenge from RFK Jr.
Next article： BioMarin wins approval for gene therapy to treat hemophilia A

explore

Jerome Adams on the need for new antivirals for Covid

PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

Gene therapy denied for Afghan refugee whose father aided U.S.

ThePashaichildren(fromleft):Abubakar,Mohammad,andSufyan.Illustration:STAT;PhotoCourtesyOnasweltering

New air purifier tech could be key to improving indoor air quality

AdobeUntiltheearly20thcentury,Americaregularlyexperiencedbrutallydestructiveurbanfires.Conflagration

House GOP plan to stem drug shortages differs from Democrats’

Rep.CathyMcMorrisRodgers(R-Wash.),chairoftheHouseEnergyandCommerceCommittee.AnnaMoneymaker/GettyImag